These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8585927)

  • 1. Lipid mediators in the rat retina: light exposure and trauma elicit leukotriene B4 release in vitro.
    Reinboth JJ; Gautschi K; Clausen M; Remé CE
    Curr Eye Res; 1995 Nov; 14(11):1001-8. PubMed ID: 8585927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia accelerates retinal light damage in rats.
    Organisciak DT; Darrow RM; Noell WK; Blanks JC
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):997-1008. PubMed ID: 7730034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina.
    Remé CE; Malnoë A; Jung HH; Wei Q; Munz K
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):78-90. PubMed ID: 8300366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene B4.
    Crooks SW; Stockley RA
    Int J Biochem Cell Biol; 1998 Feb; 30(2):173-8. PubMed ID: 9608670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching.
    Grimm C; Wenzel A; Williams T; Rol P; Hafezi F; Remé C
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):497-505. PubMed ID: 11157889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-78773: a selective, potent 5-lipoxygenase inhibitor.
    Bell RL; Brooks DW; Young PR; Lanni C; Stewart AO; Bouska J; Malo PE; Carter GW
    J Lipid Mediat; 1993; 6(1-3):259-64. PubMed ID: 8395248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
    Mangino MJ; Murphy MK; Anderson CB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):75-81. PubMed ID: 8169854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.
    Guidot DM; Repine MJ; Westcott JY; Repine JE
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8156-9. PubMed ID: 8058773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
    Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
    J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
    J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-lipoxygenase inhibitory activity of zileuton.
    Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
    J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.
    Bertrán X; Mañé J; Fernández-Bañares F; Castellá E; Bartolí R; Ojanguren I; Esteve M; Gassull MA
    Gut; 1996 Jun; 38(6):899-904. PubMed ID: 8984030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton.
    Gaber F; James A; Delin I; Wetterholm A; Sampson AP; Dahlén B; Dahlén SE; Kumlin M
    J Allergy Clin Immunol; 2007 May; 119(5):1267-8. PubMed ID: 17258303
    [No Abstract]   [Full Text] [Related]  

  • 17. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of leukotriene synthesis by azelastine.
    Hamasaki Y; Shafigeh M; Yamamoto S; Sato R; Zaitu M; Muro E; Kobayashi I; Ichimaru T; Tasaki H; Miyazaki S
    Ann Allergy Asthma Immunol; 1996 May; 76(5):469-75. PubMed ID: 8630722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
    Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
    Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release.
    Jung H; Remé C
    Graefes Arch Clin Exp Ophthalmol; 1994 Mar; 232(3):167-75. PubMed ID: 8188067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.